Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 2;177(4):865-880.e21.
doi: 10.1016/j.cell.2019.03.046. Epub 2019 Apr 25.

Structure and Degradation of Circular RNAs Regulate PKR Activation in Innate Immunity

Affiliations
Free article

Structure and Degradation of Circular RNAs Regulate PKR Activation in Innate Immunity

Chu-Xiao Liu et al. Cell. .
Free article

Abstract

Circular RNAs (circRNAs) produced from back-splicing of exons of pre-mRNAs are widely expressed, but current understanding of their functions is limited. These RNAs are stable in general and are thought to have unique structural conformations distinct from their linear RNA cognates. Here, we show that endogenous circRNAs tend to form 16-26 bp imperfect RNA duplexes and act as inhibitors of double-stranded RNA (dsRNA)-activated protein kinase (PKR) related to innate immunity. Upon poly(I:C) stimulation or viral infection, circRNAs are globally degraded by RNase L, a process required for PKR activation in early cellular innate immune responses. Augmented PKR phosphorylation and circRNA reduction are found in peripheral blood mononuclear cells (PBMCs) derived from patients with autoimmune disease systemic lupus erythematosus (SLE). Importantly, overexpression of the dsRNA-containing circRNA in PBMCs or T cells derived from SLE can alleviate the aberrant PKR activation cascade, thus providing a connection between circRNAs and SLE.

Keywords: PKR; RNase L; autoimmune disease; circRNA degradation; circRNA structure; circRNAs; circular RNAs; double-stranded RNAs; innate immune responses; systemic lupus erythematosus.

PubMed Disclaimer

Comment in

Publication types

MeSH terms